ADV36 adipogenic adenovirus in human liver disease

doi:10.3748/wjg.v20.i40.14706

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 40

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6768)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-3) series.

Item

Count

PDF

422

WORD

268

HTML

3775

Figures (1-8)

216

Tables (1-3)

169

Sum=4850

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1040

Download

878

Sum=1918

Oct 28, 2014 (publication date) through Sep 1, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Oct 28, 2014; 20(40): 14706-14716
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14706

Full Size Figure Download Figure

Figure 8 Compound ADV36/ADV37 seropositivity is associated with a risk profile more similar to ADV37 seropositivity, whose effect is not blunted by ADV36 seropositivity. NAFLD: Non-alcoholic fatty liver disease.

Citation: Trovato FM, Catalano D, Garozzo A, Martines GF, Pirri C, Trovato GM. ADV36 adipogenic adenovirus in human liver disease. World J Gastroenterol 2014; 20(40): 14706-14716
URL: https://www.wjgnet.com/1007-9327/full/v20/i40/14706.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i40.14706